Léon Gueswendé Blaise Savadogo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Léon Gueswendé Blaise Savadogo has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Ziemlé Clément Méda
Institut Supérieur des Sciences de la Santé, Université Nazi BONI, Bobo-Dioulasso, Burkina Faso
6 shared publications - Almoustapha Mahamane Wazodan
Bobo-Dioulasso Doctoral School of Health Sciences at Nazi Boni University
3 shared publications - Bernard Ilboudo
Centre Muraz
3 shared publications - Isidore Tiandiogo Traoré
Nazi Boni University
3 shared publications - Bapougouni Philippe Christian Yonli
Permanent secretary office of the national council responding to HIV/AIDS and sexually transmitted infections, Ouagadougou
2 shared publications - Cheick Ahmed Ouattara
Agence de Formation de Recherche et d’Expertise en Santé pour l’Afrique (AFRICSanté), Bobo-Dioulasso 01 BP 298, Burkina Faso
2 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by IWA Publishing in Water Supply
Physicochemical and microbiological quality of drinking water in rural communities surrounding the Soum Dam Agropole, Burkina Faso
Access to safe drinking water is essential for human health, yet contamination with fecal matter remains widespread in areas with poor hygiene and sanitation. This study assessed the physico-chemical and microbiological quality of drinking water from water sources and households in five villages located at different distances from the Soum dam in Burkina Faso. Four cross-sectional surveys were conducted between August 2023 to July 2024, and 760 water samples from 189 sources and 571 households water. Parameters included pH, temperature, electrical conductivity, turbidity, total coliforms, Escherichia coli, fecal enterorocci, and Salmonella. Elevated temperatures were observed in 82.0% of samples, while 38.5% had low pH. Total coliforms and E. coli were detected in 92 and 67.1% of samples, respectively. Significant differences in microbiological contamination by location were observed for fecal enterococci in water sources and E. coli and fecal enterococci in household water. In multivariable analysis, households in Seguedin and Soala had higher adjusted odds of contamination than those in Soum (AOR = 2.78 and AOR = 3.99, respectively). Pump-based (boreholes) water sources were associated with lower odds of contamination (AOR = 0.39), as was perception of water-related health risks (AOR = 0.64). These findings highlight substantial microbiological contamination and support targeted interventions.
- 4 November 2026
- Published by IWA Publishing in Water Supply
Open AccessPhysicochemical and microbiological quality of drinking water in rural communities surrounding the Soum Dam Agropole, Burkina Faso
Access to safe drinking water is essential for human health, yet contamination with fecal matter remains widespread in areas with poor hygiene and sanitation. This study assessed the physico-chemical and microbiological quality of drinking water from water sources and households in five villages located at different distances from the Soum dam in Burkina Faso. Four cross-sectional surveys were conducted between August 2023 to July 2024, and 760 water samples from 189 sources and 571 households water. Parameters included pH, temperature, electrical conductivity, turbidity, total coliforms, Escherichia coli, fecal enterorocci, and Salmonella. Elevated temperatures were observed in 82.0% of samples, while 38.5% had low pH. Total coliforms and E. coli were detected in 92 and 67.1% of samples, respectively. Significant differences in microbiological contamination by location were observed for fecal enterococci in water sources and E. coli and fecal enterococci in household water. In multivariable analysis, households in Seguedin and Soala had higher adjusted odds of contamination than those in Soum (AOR = 2.78 and AOR = 3.99, respectively). Pump-based (boreholes) water sources were associated with lower odds of contamination (AOR = 0.39), as was perception of water-related health risks (AOR = 0.64). These findings highlight substantial microbiological contamination and support targeted interventions.
- Open Access
- 30 June 2026
- Published by Centre National de la Recherche Scientifique et Technologique in Sciences de la Santé
- Vol. 49 (1) , 175-192
Co-construction of strategies for Elimination of mother-to-child transmission of HIV in Burkina Faso : results of a multi-stakeholder workshop
Introduction Burkina Faso aims to eliminate mother-to-child transmission of HIV (eTMCT). Despite the many efforts made to achieve eTMCT, indicators across the prevention cascade remain low. The aim of this study is to propose co-developed strategies to achieve the eTMCT target in Burkina Faso. Materials and Methods This was a qualitative cross-sectional study based on a solution-focused approach to strengthen the eMTCT programme. We conducted a multi-stakeholder participatory workshop with national eMTCT stakeholders. The results of a study on the functioning of the eMTCT-HIV programme in Burkina Faso served as a guiding thread in the working groups to identify causes and formulate solutions. Results This approach brought together stakeholders of the e-TME-HIV programme in Burkina Faso. Among the solutions that emerged were: i) addressing the turnover of trained health workers, ii) advocating to decision-makers to integrate e-TME modules into training schools, iii) the establishment of a ‘one-stop shop’ where women can be consulted, tested and supplied with antiretroviral drugs (ARVs) to avoid having to travel between departments, iv) the provision of domestic funding to ensure the sustainability of the programme’s achievements. Conclusion Relevant solutions have been proposed by national eMTCT stakeholders in Burkina Faso. To move towards the elimination of mother-to-child transmission (MTCT) in Burkina Faso, the programme now has solutions to strengthen its interventions.
- 30 June 2026
- Published by Centre National de la Recherche Scientifique et Technologique in Sciences de la Santé
- Vol. 49 (1) , 175-192
Open AccessCo-construction of strategies for Elimination of mother-to-child transmission of HIV in Burkina Faso : results of a multi-stakeholder workshop
Introduction Burkina Faso aims to eliminate mother-to-child transmission of HIV (eTMCT). Despite the many efforts made to achieve eTMCT, indicators across the prevention cascade remain low. The aim of this study is to propose co-developed strategies to achieve the eTMCT target in Burkina Faso. Materials and Methods This was a qualitative cross-sectional study based on a solution-focused approach to strengthen the eMTCT programme. We conducted a multi-stakeholder participatory workshop with national eMTCT stakeholders. The results of a study on the functioning of the eMTCT-HIV programme in Burkina Faso served as a guiding thread in the working groups to identify causes and formulate solutions. Results This approach brought together stakeholders of the e-TME-HIV programme in Burkina Faso. Among the solutions that emerged were: i) addressing the turnover of trained health workers, ii) advocating to decision-makers to integrate e-TME modules into training schools, iii) the establishment of a ‘one-stop shop’ where women can be consulted, tested and supplied with antiretroviral drugs (ARVs) to avoid having to travel between departments, iv) the provision of domestic funding to ensure the sustainability of the programme’s achievements. Conclusion Relevant solutions have been proposed by national eMTCT stakeholders in Burkina Faso. To move towards the elimination of mother-to-child transmission (MTCT) in Burkina Faso, the programme now has solutions to strengthen its interventions.
- Open Access
- 18 May 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 539
Study of the coverage and the impact of the chemoprevention of seasonal malaria in Niger from 2013 to 2022: systematic review
Purpose Malaria remains a public health problem in Niger, especially among children under the age of five. To combat this scourge, since 2012, the World Health Organization (WHO) has recommended seasonal malaria chemoprevention (SMC), a strategy based on the administration of sulfadoxine-pyrimethamine and amodiaquine (SP-AQ) during the period of high transmission. This systematic review assesses the coverage, efficacy, and challenges of SMC in Niger between 2013 and 2022, analyzing its impact on malaria morbidity and mortality. Materials and methods The PRISMA guidelines were used to ensure a rigorous and comprehensive recording of the systematic review process. Through searches in five different databases, articles were imported into Zotero software, then transferred to the Covidence application, where data processing was carried out. The selected articles were independently evaluated by two reviewers. These included studies that assessed coverage, malaria incidence, and the impact of SMC. Studies published in French and English were included. Data extraction from the included studies was performed, and a quality assessment was conducted, including an evaluation of the risk of bias. Results Among the six studies, three assessed SMC coverage in all eight regions of Niger while also evaluating side effects. They showed high overall coverage but low coverage in some areas. Another study examined the impact in terms of the incidence of complicated malaria, malaria-related hospitalization, and mortality. Another publication revealed that antibody responses against the blood and pre-erythrocytic stages of P. falciparum were higher in the area where SMC was implemented. Conclusions This study demonstrates that SMC has a significant impact on reducing malaria incidence. Although there is high overall coverage, variations exist, particularly in hard-to-reach areas. Few adverse events were reported. However, very few studies are available, highlighting the need for additional research in Niger to better understand this strategy.
- 18 May 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 539
Open AccessStudy of the coverage and the impact of the chemoprevention of seasonal malaria in Niger from 2013 to 2022: systematic review
Purpose Malaria remains a public health problem in Niger, especially among children under the age of five. To combat this scourge, since 2012, the World Health Organization (WHO) has recommended seasonal malaria chemoprevention (SMC), a strategy based on the administration of sulfadoxine-pyrimethamine and amodiaquine (SP-AQ) during the period of high transmission. This systematic review assesses the coverage, efficacy, and challenges of SMC in Niger between 2013 and 2022, analyzing its impact on malaria morbidity and mortality. Materials and methods The PRISMA guidelines were used to ensure a rigorous and comprehensive recording of the systematic review process. Through searches in five different databases, articles were imported into Zotero software, then transferred to the Covidence application, where data processing was carried out. The selected articles were independently evaluated by two reviewers. These included studies that assessed coverage, malaria incidence, and the impact of SMC. Studies published in French and English were included. Data extraction from the included studies was performed, and a quality assessment was conducted, including an evaluation of the risk of bias. Results Among the six studies, three assessed SMC coverage in all eight regions of Niger while also evaluating side effects. They showed high overall coverage but low coverage in some areas. Another study examined the impact in terms of the incidence of complicated malaria, malaria-related hospitalization, and mortality. Another publication revealed that antibody responses against the blood and pre-erythrocytic stages of P. falciparum were higher in the area where SMC was implemented. Conclusions This study demonstrates that SMC has a significant impact on reducing malaria incidence. Although there is high overall coverage, variations exist, particularly in hard-to-reach areas. Few adverse events were reported. However, very few studies are available, highlighting the need for additional research in Niger to better understand this strategy.
- Open Access
- 22 April 2026
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 53 (171)
Cinquième cycle mensuel de la chimioprévention du paludisme saisonnier chez les enfants de 3 à 59 mois dans la région de Zinder, Niger: approche de son impact
L'ajout d'un cinquième cycle mensuel à la chimioprévention saisonnière du paludisme (CSP) a été proposé afin de prolonger la protection pendant les saisons de transmission prolongées au Sahel. Cette étude a évalué l'effet de l'introduction d'un cinquième cycle de CSP sur l'incidence du paludisme et sur l'utilisation des services de diagnostic et de traitement du paludisme dans le district sanitaire de Takieta, au Niger. Nous avons mené une étude quasi expérimentale, non randomisée, avant-après, avec un groupe de comparaison (conception « ici-ailleurs ») en utilisant les données de santé courantes de 19 centres de santé intégrés répartis dans deux districts sanitaires entre 2020 et 2023. Neuf centres de santé ont mis en œuvre cinq cycles mensuels de SMC (SMC5), tandis que dix centres de santé ont poursuivi la stratégie standard à quatre cycles. Les données ont été extraites du système national d'information sanitaire. Un modèle à effets fixes de différence dans les différences (DiD) a été appliqué pour estimer l'impact du cinquième cycle de SMC sur l'incidence du paludisme, l'utilisation des tests de diagnostic rapide (TDR), la positivité des TDR et la consommation de combinaisons thérapeutiques à base d'artémisinine (ACT). L'introduction d'un cinquième cycle de SMC a été associée à une réduction significative de l'incidence du paludisme, correspondant à une diminution de 2,44 cas pour 1 000 habitants pendant la période d'intervention. Cette réduction s'est accompagnée d'une amélioration de 2,99 % des performances des services de soins et d'une baisse significative des taux de positivité des TDR (p = 0,003). Cependant, les coefficients de différence dans les différences pour la consommation de TDR (158,59) et la consommation d'ACT (153,05) n'étaient pas statistiquement significatifs, ce qui indique que le SMC5 n'a pas eu d'impact mesurable sur la réduction de l'utilisation des tests diagnostiques ou des traitements antipaludiques. L'ajout d'un cinquième cycle mensuel de chimioprévention saisonnière du paludisme a été associé à une réduction de l'incidence du paludisme dans les districts étudiés pendant la période d'intervention. Cependant, aucune preuve d'une réduction correspondante de la consommation de TDR ou d'ACT n'a été trouvée. Ces résultats suggèrent que l'extension de la couverture de la SMC d'un mois supplémentaire peut réduire la charge du paludisme sans modifier de manière significative l'utilisation des services de diagnostic ou de traitement dans les établissements de santé.
- 22 April 2026
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 53 (171)
Open AccessCinquième cycle mensuel de la chimioprévention du paludisme saisonnier chez les enfants de 3 à 59 mois dans la région de Zinder, Niger: approche de son impact
L'ajout d'un cinquième cycle mensuel à la chimioprévention saisonnière du paludisme (CSP) a été proposé afin de prolonger la protection pendant les saisons de transmission prolongées au Sahel. Cette étude a évalué l'effet de l'introduction d'un cinquième cycle de CSP sur l'incidence du paludisme et sur l'utilisation des services de diagnostic et de traitement du paludisme dans le district sanitaire de Takieta, au Niger. Nous avons mené une étude quasi expérimentale, non randomisée, avant-après, avec un groupe de comparaison (conception « ici-ailleurs ») en utilisant les données de santé courantes de 19 centres de santé intégrés répartis dans deux districts sanitaires entre 2020 et 2023. Neuf centres de santé ont mis en œuvre cinq cycles mensuels de SMC (SMC5), tandis que dix centres de santé ont poursuivi la stratégie standard à quatre cycles. Les données ont été extraites du système national d'information sanitaire. Un modèle à effets fixes de différence dans les différences (DiD) a été appliqué pour estimer l'impact du cinquième cycle de SMC sur l'incidence du paludisme, l'utilisation des tests de diagnostic rapide (TDR), la positivité des TDR et la consommation de combinaisons thérapeutiques à base d'artémisinine (ACT). L'introduction d'un cinquième cycle de SMC a été associée à une réduction significative de l'incidence du paludisme, correspondant à une diminution de 2,44 cas pour 1 000 habitants pendant la période d'intervention. Cette réduction s'est accompagnée d'une amélioration de 2,99 % des performances des services de soins et d'une baisse significative des taux de positivité des TDR (p = 0,003). Cependant, les coefficients de différence dans les différences pour la consommation de TDR (158,59) et la consommation d'ACT (153,05) n'étaient pas statistiquement significatifs, ce qui indique que le SMC5 n'a pas eu d'impact mesurable sur la réduction de l'utilisation des tests diagnostiques ou des traitements antipaludiques. L'ajout d'un cinquième cycle mensuel de chimioprévention saisonnière du paludisme a été associé à une réduction de l'incidence du paludisme dans les districts étudiés pendant la période d'intervention. Cependant, aucune preuve d'une réduction correspondante de la consommation de TDR ou d'ACT n'a été trouvée. Ces résultats suggèrent que l'extension de la couverture de la SMC d'un mois supplémentaire peut réduire la charge du paludisme sans modifier de manière significative l'utilisation des services de diagnostic ou de traitement dans les établissements de santé.
- Open Access
- 30 May 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 539
Study of the coverage and the impact of the chemoprevention of seasonal malaria in Niger from 2013 to 2022: systematic review
Purpose Malaria remains a public health problem in Niger, especially among children under the age of five. To combat this scourge, since 2012, the World Health Organization (WHO) has recommended seasonal malaria chemoprevention (SMC), a strategy based on the administration of sulfadoxine-pyrimethamine and amodiaquine (SP-AQ) during the period of high transmission. This systematic review assesses the coverage, efficacy, and challenges of SMC in Niger between 2013 and 2022, analyzing its impact on malaria morbidity and mortality. Materials and methods The PRISMA guidelines were used to ensure a rigorous and comprehensive recording of the systematic review process. Through searches in five different databases, articles were imported into Zotero software, then transferred to the Covidence application, where data processing was carried out. The selected articles were independently evaluated by two reviewers. These included studies that assessed coverage, malaria incidence, and the impact of SMC. Studies published in French and English were included. Data extraction from the included studies was performed, and a quality assessment was conducted, including an evaluation of the risk of bias. Results Among the six studies, three assessed SMC coverage in all eight regions of Niger while also evaluating side effects. They showed high overall coverage but low coverage in some areas. Another study examined the impact in terms of the incidence of complicated malaria, malaria-related hospitalization, and mortality. Another publication revealed that antibody responses against the blood and pre-erythrocytic stages of P. falciparum were higher in the area where SMC was implemented. Conclusions This study demonstrates that SMC has a significant impact on reducing malaria incidence. Although there is high overall coverage, variations exist, particularly in hard-to-reach areas. Few adverse events were reported. However, very few studies are available, highlighting the need for additional research in Niger to better understand this strategy.
- 30 May 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 539
Open AccessStudy of the coverage and the impact of the chemoprevention of seasonal malaria in Niger from 2013 to 2022: systematic review
Purpose Malaria remains a public health problem in Niger, especially among children under the age of five. To combat this scourge, since 2012, the World Health Organization (WHO) has recommended seasonal malaria chemoprevention (SMC), a strategy based on the administration of sulfadoxine-pyrimethamine and amodiaquine (SP-AQ) during the period of high transmission. This systematic review assesses the coverage, efficacy, and challenges of SMC in Niger between 2013 and 2022, analyzing its impact on malaria morbidity and mortality. Materials and methods The PRISMA guidelines were used to ensure a rigorous and comprehensive recording of the systematic review process. Through searches in five different databases, articles were imported into Zotero software, then transferred to the Covidence application, where data processing was carried out. The selected articles were independently evaluated by two reviewers. These included studies that assessed coverage, malaria incidence, and the impact of SMC. Studies published in French and English were included. Data extraction from the included studies was performed, and a quality assessment was conducted, including an evaluation of the risk of bias. Results Among the six studies, three assessed SMC coverage in all eight regions of Niger while also evaluating side effects. They showed high overall coverage but low coverage in some areas. Another study examined the impact in terms of the incidence of complicated malaria, malaria-related hospitalization, and mortality. Another publication revealed that antibody responses against the blood and pre-erythrocytic stages of P. falciparum were higher in the area where SMC was implemented. Conclusions This study demonstrates that SMC has a significant impact on reducing malaria incidence. Although there is high overall coverage, variations exist, particularly in hard-to-reach areas. Few adverse events were reported. However, very few studies are available, highlighting the need for additional research in Niger to better understand this strategy.
- Open Access
- 18 March 2025
- Published by MDPI AG in Preprints.org
Patient Companions’ Knowledge and Practice of Infection Prevention and Control Measures in Health Facilities in the City of Bobo-Dioulasso, Burkina Faso
Healthcare in a hospital environment frequently involves patient companions who can serve as reservoirs and transmitters of infection. This study aimed to assess the knowledge and practices of patient companions regarding infection prevention and control (IPC) in healthcare settings of Bobo Dioulasso (Burkina Faso). A cross-sectional study including patient companions was conducted at Sourô Sanou University Hospital (CHUSS) and the Do and Dafra district hospitals. Multilevel linear regression model was employed to assess the associations between companion characteristics and their level of knowledge or practice. The statistical significance level was set at 5% for all analyses. A total of 789 patient companions were included. The average knowledge score on IPC was 32 out of 100. The average score for IPC practices in healthcare facilities was 81.0 out of 100. Male gender (P=0.029), urban residence (P=0.034), widower status (P=0.001), secondary education and above (P=0.000), and awareness (P=0.000) were found to be associated with a higher level of IPC knowledge. Secondary education and above (P=0.010), awareness (P=0.000), CHUSS and Do (P=0.012) were factors associated with good IPC practices. This results showed patient companions deficiency in IPC knowledge and practice. Main factors of this deficit were a paucity of education and insufficient awareness.
- 18 March 2025
- Published by MDPI AG in Preprints.org
Open AccessPatient Companions’ Knowledge and Practice of Infection Prevention and Control Measures in Health Facilities in the City of Bobo-Dioulasso, Burkina Faso
Healthcare in a hospital environment frequently involves patient companions who can serve as reservoirs and transmitters of infection. This study aimed to assess the knowledge and practices of patient companions regarding infection prevention and control (IPC) in healthcare settings of Bobo Dioulasso (Burkina Faso). A cross-sectional study including patient companions was conducted at Sourô Sanou University Hospital (CHUSS) and the Do and Dafra district hospitals. Multilevel linear regression model was employed to assess the associations between companion characteristics and their level of knowledge or practice. The statistical significance level was set at 5% for all analyses. A total of 789 patient companions were included. The average knowledge score on IPC was 32 out of 100. The average score for IPC practices in healthcare facilities was 81.0 out of 100. Male gender (P=0.029), urban residence (P=0.034), widower status (P=0.001), secondary education and above (P=0.000), and awareness (P=0.000) were found to be associated with a higher level of IPC knowledge. Secondary education and above (P=0.010), awareness (P=0.000), CHUSS and Do (P=0.012) were factors associated with good IPC practices. This results showed patient companions deficiency in IPC knowledge and practice. Main factors of this deficit were a paucity of education and insufficient awareness.
- Open Access
- 25 October 2023
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 8 (11) , 482
Spatio-Temporal Determinants of Dengue Epidemics in the Central Region of Burkina Faso
The aim of this study was to analyze the spatio-temporal distribution and determinants of the 2017 dengue epidemic in Burkina Faso. A principal component analysis of meteorological and environmental factors was performed to reduce dimensions and avoid collinearities. An initial generalized additive model assessed the impact of the components derived from this analysis on dengue incidence. Dengue incidence increased mainly with relative humidity, precipitation, normalized difference vegetation index and minimum temperature with an 8-week lag. A Kulldoff Satscan scan was used to identify high-risk dengue clusters, and a second generalized additive model assessed the risk of a health area being at high risk according to land-use factors. The spatio-temporal distribution of dengue fever was heterogeneous and strongly correlated with meteorological factors. The rural communes of Sabaa and Koubri were the areas most at risk. This study provides useful information for planning targeted dengue control strategies in Burkina Faso.
- 25 October 2023
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 8 (11) , 482
Open AccessSpatio-Temporal Determinants of Dengue Epidemics in the Central Region of Burkina Faso
The aim of this study was to analyze the spatio-temporal distribution and determinants of the 2017 dengue epidemic in Burkina Faso. A principal component analysis of meteorological and environmental factors was performed to reduce dimensions and avoid collinearities. An initial generalized additive model assessed the impact of the components derived from this analysis on dengue incidence. Dengue incidence increased mainly with relative humidity, precipitation, normalized difference vegetation index and minimum temperature with an 8-week lag. A Kulldoff Satscan scan was used to identify high-risk dengue clusters, and a second generalized additive model assessed the risk of a health area being at high risk according to land-use factors. The spatio-temporal distribution of dengue fever was heterogeneous and strongly correlated with meteorological factors. The rural communes of Sabaa and Koubri were the areas most at risk. This study provides useful information for planning targeted dengue control strategies in Burkina Faso.
- Open Access
- 30 September 2023
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 14 (9)
Sub-optimal satisfaction of people living with HIV and AIDS regarding their care in Burkina Faso, West Africa
People living with HIV (PLHIV) satisfaction regarding to care could play an important role in the elimination of HIV epidemic by 2030. We assessed Burkina Faso PLHIV satisfaction regarding to their care, and identified its associated factors. A representative nationwide cross‑sectional study was performed in 2021‑2022 in 30 HIV/AIDS care sites. PLHIV aged at least 18 years, receiving ART for six months or plus were included. Individual and structural data were collected using a questionnaire administered by trained investigators. Satisfaction with HIV/AIDS care was explored using six components (reception, waiting time to medical visit, care environment, sharing updated information on HIV AIDS, answering to PLHIV questions, and providing tailored care and advice to PLHIV needs). Factors associated with satisfaction were identified using logistic regressions. 448 PLHIV were considered in this analysis. Median age was 46 years. Overall satisfaction regarding to care was 40,8% (95% confidence interval 95% CI 36.2‑45.6). Specifically, it was 90.6, 54.9, 85.3, 75.7, 90.8, and 93.3% regarding to reception, waiting time, care environment, sharing updated information, answering to PLHIV questions, and providing tailored care and advice to PLHIV needs, respectively. Attending to medical visits in community‑based organization (CBO) and private clinics (adjusted odds ratio aOR 1.82, 95% CI 1.14‑2.93, P0.001), as well as in tertiary hospitals (aOR 2.37, 95% CI 1.45‑3.87, P=0.001) were positively associated with PLHIV satisfaction. Burkina Faso PLHIV are generally unsatisfied with care. HIV national authorities should promote HIV care in CBO clinics model in the delivery of HIV services in others public sites.
- 30 September 2023
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 14 (9)
Open AccessSub-optimal satisfaction of people living with HIV and AIDS regarding their care in Burkina Faso, West Africa
People living with HIV (PLHIV) satisfaction regarding to care could play an important role in the elimination of HIV epidemic by 2030. We assessed Burkina Faso PLHIV satisfaction regarding to their care, and identified its associated factors. A representative nationwide cross‑sectional study was performed in 2021‑2022 in 30 HIV/AIDS care sites. PLHIV aged at least 18 years, receiving ART for six months or plus were included. Individual and structural data were collected using a questionnaire administered by trained investigators. Satisfaction with HIV/AIDS care was explored using six components (reception, waiting time to medical visit, care environment, sharing updated information on HIV AIDS, answering to PLHIV questions, and providing tailored care and advice to PLHIV needs). Factors associated with satisfaction were identified using logistic regressions. 448 PLHIV were considered in this analysis. Median age was 46 years. Overall satisfaction regarding to care was 40,8% (95% confidence interval 95% CI 36.2‑45.6). Specifically, it was 90.6, 54.9, 85.3, 75.7, 90.8, and 93.3% regarding to reception, waiting time, care environment, sharing updated information, answering to PLHIV questions, and providing tailored care and advice to PLHIV needs, respectively. Attending to medical visits in community‑based organization (CBO) and private clinics (adjusted odds ratio aOR 1.82, 95% CI 1.14‑2.93, P0.001), as well as in tertiary hospitals (aOR 2.37, 95% CI 1.45‑3.87, P=0.001) were positively associated with PLHIV satisfaction. Burkina Faso PLHIV are generally unsatisfied with care. HIV national authorities should promote HIV care in CBO clinics model in the delivery of HIV services in others public sites.
- Open Access
- 30 September 2023
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 14 (9) , 9
Sub-optimal satisfaction of people living with HIV and AIDS regarding their care in Burkina Faso, West Africa
People living with HIV (PLHIV) satisfaction regarding to care could play an important role in the elimination of HIV epidemic by 2030. We assessed Burkina Faso PLHIV satisfaction regarding to their care, and identified its associated factors. A representative nationwide cross‑sectional study was performed in 2021‑2022 in 30 HIV/AIDS care sites. PLHIV aged at least 18 years, receiving ART for six months or plus were included. Individual and structural data were collected using a questionnaire administered by trained investigators. Satisfaction with HIV/AIDS care was explored using six components (reception, waiting time to medical visit, care environment, sharing updated information on HIV AIDS, answering to PLHIV questions, and providing tailored care and advice to PLHIV needs). Factors associated with satisfaction were identified using logistic regressions. 448 PLHIV were considered in this analysis. Median age was 46 years. Overall satisfaction regarding to care was 40,8% (95% confidence interval 95% CI 36.2‑45.6). Specifically, it was 90.6, 54.9, 85.3, 75.7, 90.8, and 93.3% regarding to reception, waiting time, care environment, sharing updated information, answering to PLHIV questions, and providing tailored care and advice to PLHIV needs, respectively. Attending to medical visits in community‑based organization (CBO) and private clinics (adjusted odds ratio aOR 1.82, 95% CI 1.14‑2.93, P0.001), as well as in tertiary hospitals (aOR 2.37, 95% CI 1.45‑3.87, P=0.001) were positively associated with PLHIV satisfaction. Burkina Faso PLHIV are generally unsatisfied with care. HIV national authorities should promote HIV care in CBO clinics model in the delivery of HIV services in others public sites.
- 30 September 2023
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 14 (9) , 9
Open AccessSub-optimal satisfaction of people living with HIV and AIDS regarding their care in Burkina Faso, West Africa
People living with HIV (PLHIV) satisfaction regarding to care could play an important role in the elimination of HIV epidemic by 2030. We assessed Burkina Faso PLHIV satisfaction regarding to their care, and identified its associated factors. A representative nationwide cross‑sectional study was performed in 2021‑2022 in 30 HIV/AIDS care sites. PLHIV aged at least 18 years, receiving ART for six months or plus were included. Individual and structural data were collected using a questionnaire administered by trained investigators. Satisfaction with HIV/AIDS care was explored using six components (reception, waiting time to medical visit, care environment, sharing updated information on HIV AIDS, answering to PLHIV questions, and providing tailored care and advice to PLHIV needs). Factors associated with satisfaction were identified using logistic regressions. 448 PLHIV were considered in this analysis. Median age was 46 years. Overall satisfaction regarding to care was 40,8% (95% confidence interval 95% CI 36.2‑45.6). Specifically, it was 90.6, 54.9, 85.3, 75.7, 90.8, and 93.3% regarding to reception, waiting time, care environment, sharing updated information, answering to PLHIV questions, and providing tailored care and advice to PLHIV needs, respectively. Attending to medical visits in community‑based organization (CBO) and private clinics (adjusted odds ratio aOR 1.82, 95% CI 1.14‑2.93, P0.001), as well as in tertiary hospitals (aOR 2.37, 95% CI 1.45‑3.87, P=0.001) were positively associated with PLHIV satisfaction. Burkina Faso PLHIV are generally unsatisfied with care. HIV national authorities should promote HIV care in CBO clinics model in the delivery of HIV services in others public sites.